C07K 16/247
Il-4
Official title: {il-4}
C07K16/247 (Il-4) appears on 107 US grants and 212 published applications in this corpus.
Search patents in C07K- Granted patents
- 107
- Published applications
- 212
- Assignees
- 98
- Inventors
- 415
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 5 | 0 |
| 1998 | 5 | 0 |
| 1999 | 6 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 2 |
| 2003 | 1 | 3 |
| 2004 | 1 | 2 |
| 2005 | 1 | 2 |
| 2006 | 4 | 2 |
| 2007 | 1 | 4 |
| 2008 | 0 | 2 |
| 2009 | 3 | 4 |
| 2010 | 3 | 7 |
| 2011 | 0 | 4 |
| 2012 | 1 | 6 |
| 2013 | 2 | 16 |
| 2014 | 2 | 8 |
| 2015 | 3 | 3 |
| 2016 | 2 | 9 |
| 2017 | 5 | 7 |
| 2018 | 4 | 9 |
| 2019 | 2 | 9 |
| 2020 | 5 | 20 |
| 2021 | 9 | 13 |
| 2022 | 4 | 20 |
| 2023 | 6 | 19 |
| 2024 | 14 | 18 |
| 2025 | 5 | 10 |
| 2026 | 3 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bispecific caninized antibodies and bispecific binding partners for treating atopic dermatitis21 Jul 2026US 12,686,721 B2Intervet Inc.
- Bispecific caninized antibodies for treating atopic dermatitis19 May 2026US 12,630,640 B2Intervet Inc.
- Antibody for binding to interleukin 4 receptor14 Apr 2026US 12,600,771 B2Connect Biopharma Hongkong Limited
- JAK1 pathway inhibitors for the treatment of prurigo nodularis8 Apr 2025US 12,268,667 B2Incyte Corporation
- Vaccine molecules8 Apr 2025US 12,268,736 B2University of Oslo
- Rna replicons, compositions and methods of use thereof24 Sep 2026US 2026/0286321 A1Able Sciences, Inc.
- Trispecific binding proteins that bind interleukin-4 and interleukin-1320 Aug 2026US 2026/0242461 A1Sanofi
- Improved phox2b pc-car generation based on structure and saturation mutagenesis20 Aug 2026US 2026/0243766 A1The Children’s Hospital of Philadelphia
- Canine antibodies to canine il-1313 Aug 2026US 2026/0234236 A1Intervet Inc.
- Bispecific binding agents for use in companion animals13 Aug 2026US 2026/0234262 A1Invetx, Inc.
Most cited
By later US patents
- Readily isolated bispecific antibodies with native immunoglobulin format169US 8,586,713 B2Regeneron Pharmaceuticals, Inc. · 2013
- Multiple cytokine protein complexes145US 6,617,135 B1EMD Lexigen Research Center Corp. · 2003
- Humanized monoclonal antibodies against human interleukin-4109US 5,705,154 ASchering Corporation · 1998
- Cloning and exprssion of humanized monoclonal antibodies against human interluekin-468US 5,770,403 ASchering Corporation · 1998
- Method to inhibit T cell interactions with soluble B761US 6,887,471 B1Bristol-Myers Squibb Company · 2005